N-Nitroso Nintedanib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Nintedanib is used to treat idiopathic pulmonary fibrosis. It helps prevent changes to the lung tissue. It is also used to treat people with a chronic (long-lasting) interstitial lung disease in which lung fibrosis continues to progress or becomes worse.N-Nitroso Nintedanib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nintedanib Impurity 1 CAS NO:NA Chemically represented as Methyl (Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-1-nitroso-2-oxoindoline-6-carboxylate . Synchemia is the leading manufacturing and exporter of N-Nitroso Nintedanib Impurity 1 .We supply N-Nitroso Nintedanib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141363 |
| CAS No | NA |
| Mol.F. | C22H19F3N2O |
| Mol.Wt. | 384.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141364 |
| CAS No | NA |
| Mol.F. | C26H27N5O4 |
| Mol.Wt. | 473.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141365 |
| CAS No | NA |
| Mol.F. | C20H26N2O2 |
| Mol.Wt. | 326.44 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141366 |
| CAS No | 2680528-95-2 |
| Mol.F. | C19H24N2O2 |
| Mol.Wt. | 312.41 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141368 |
| CAS No | NA |
| Mol.F. | C8H22N6O |
| Mol.Wt. | 218.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141369 |
| CAS No | NA |
| Mol.F. | C8H21N7O2 |
| Mol.Wt. | 247.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141370 |
| CAS No | NA |
| Mol.F. | C8H21N7O2 |
| Mol.Wt. | 247.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141371 |
| CAS No | NA |
| Mol.F. | C8H20N8O3 |
| Mol.Wt. | 276.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141372 |
| CAS No | NA |
| Mol.F. | C13H17Br2N3O2 |
| Mol.Wt. | 407.1 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141373 |
| CAS No | NA |
| Mol.F. | C9H8Cl2N4O |
| Mol.Wt. | 259.1 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141374 |
| CAS No | NA |
| Mol.F. | C5H7N3O3 |
| Mol.Wt. | 157.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141375 |
| CAS No | NA |
| Mol.F. | C11H10Cl2N4O2 |
| Mol.Wt. | 301.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141376 |
| CAS No | NA |
| Mol.F. | C18H18Cl2N2O5 |
| Mol.Wt. | 413.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141377 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O5 |
| Mol.Wt. | 399.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141378 |
| CAS No | NA |
| Mol.F. | C19H20Cl2N2O5 |
| Mol.Wt. | 427.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141379 |
| CAS No | NA |
| Mol.F. | C15H12Cl2N2O5 |
| Mol.Wt. | 371.2 |
| INV STATUS | CUSTOM SYNTHESIS |